The Evaluation of OrCel for the Treatment of Venous Ulcers

Sponsor
Ortec International (Industry)
Overall Status
Unknown status
CT.gov ID
NCT00270972
Collaborator
(none)
60
10
6

Study Details

Study Description

Brief Summary

This study was designed to confirm the clinical benefits and safety of OrCel in the treatment of venous ulcers. OrCel and standard care are compared to standard care alone. Standard care consists of currently accepted compression therapy.

Patients are treated for 12 weeks. Patients with healed ulcers are followed for an additional 12 weeks to assess durability of the healed wound.

Condition or Disease Intervention/Treatment Phase
  • Device: Bilayered Cellular Matrix (OrCel)
N/A

Study Design

Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Confirmatory Study to Evaluate the Safety and Efficacy of Cryopreserved Bilayered Cellular Matrix (ORCEL) for the Treatment of Venous Ulcers
Study Start Date :
Sep 1, 2005

Outcome Measures

Primary Outcome Measures

  1. Investigator Assessment of wound healing []

Secondary Outcome Measures

  1. Planimetric assessment of wound healing []

  2. Photographic assessment of wound healing []

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Any race, between 18 and 85 years of age

  • Male or female

  • Chronic venous insufficiency

  • Ulcer size between 2 and 20 sq cm, inclusive

  • Ulcer present for at least one month

  • ABI >0.7

Exclusion Criteria:
  • Decrease in wound size >35% during Screening Phase

  • Infection at ulcer site

  • Uncontrolled diabetes mellitus

  • Malnutrition

  • Previous treatment with excluded medications

Contacts and Locations

Locations

Site City State Country Postal Code
1 Baptist Medical Center South Montgomery Alabama United States 36116
2 Associated Foot and Ankle Specialists Phoenix Arizona United States 85015
3 Eden Podiatry Group Castro Valley California United States 94546
4 PPH Center for Wound Care and Hyperbaric Medicine Poway California United States 92064
5 Wound Healing Center Terre Haute Indiana United States 47807
6 Southside Hospital Bay Shore New York United States 11706
7 St Luke's Roosevelt New York New York United States 10025
8 Center for Advanced Wound Care Reading Pennsylvania United States 19601
9 Warren General Hospital Warren Pennsylvania United States 16365
10 Hyperbaric and Wound Care Associates Milwaukee Wisconsin United States 53215

Sponsors and Collaborators

  • Ortec International

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00270972
Other Study ID Numbers:
  • 100-VLU-02-CLN
First Posted:
Dec 29, 2005
Last Update Posted:
Jun 5, 2006
Last Verified:
Jun 1, 2006
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 5, 2006